Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

37.59
+0.14000.37%
Post-market: 37.590.00000.00%19:30 EDT
Volume:429.25K
Turnover:16.16M
Market Cap:3.62B
PE:-19.22
High:38.27
Open:37.74
Low:37.24
Close:37.45
52wk High:42.68
52wk Low:24.24
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.75
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.02
PE(LYR):-29.25

Loading ...

IDEAYA enrolls first patient in Phase 1/2 trial of PRMT5 inhibitor IDE892 with MAT2A drug IDE397 in MTAP-deleted tumors

Reuters
·
Jun 15

IDEAYA Biosciences Price Target Maintained With a $58.00/Share by Wedbush

Dow Jones
·
Jun 12

IDEAYA Biosciences Raises $324 Million in Equity Offering

TIPRANKS
·
Jun 11

Ideaya Biosciences Closes $345 Million Public Offering

MT Newswires Live
·
Jun 11

IDEAYA Biosciences prices $345 million public offering at $27 a share

Reuters
·
Jun 11

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Nuvalent, Sirius XM, J.M. Smucker

Reuters
·
Jun 09

BUZZ-IDEAYA Biosciences drops on $300 mln equity raise

Reuters
·
Jun 09

IDEAYA Biosciences Shares Down 8.6% Premarket After Co Announces Pricing of $300 Mln Stock Offering

THOMSON REUTERS
·
Jun 09

IDEAYA Biosciences - Shares Priced at $27 Each

THOMSON REUTERS
·
Jun 09

BRIEF-Ideaya Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
Jun 09

Ideaya Biosciences Plans $300 Million Public Offering

MT Newswires Live
·
Jun 09

Ideaya Biosciences announces $300M common stock offering

TIPRANKS
·
Jun 09

IDEAYA Biosciences plans public offering of up to $300 million in common stock, pre-funded warrants

Reuters
·
Jun 09

IDEAYA Biosciences - to Grant Underwriters 30-Day Option to Purchase up to $45 Mln of Common Stock

THOMSON REUTERS
·
Jun 09

IDEAYA Biosciences - Announces Proposed Public Offering of up to $300 Mln in Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Jun 09

IDEAYA Biosciences files Form 3 for Chief Development Officer Theodora Ross

Reuters
·
Jun 06

Analysts Have Conflicting Sentiments on These Healthcare Companies: IDEAYA Biosciences (IDYA) and Diaceutics (OtherDIUXF)

TIPRANKS
·
Jun 04

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and IDEAYA Biosciences (IDYA)

TIPRANKS
·
Jun 03